CHWY Chewy Inc. Class A

Chewy Launches Compounded Medications for Pets, Plans to Offer it as a Service to Veterinarians in Future

Chewy, Inc. (“Chewy”) (NYSE: CHWY), the leader in pet e-commerce, announced today that it is expanding its Pharmacy (Rx) business to now offer compounded medications that are customized to the specific needs of pets.

The launch of compounding medications comes on the heels of Chewy’s newly debuted “Connect With a Vet” telehealth service and advances the company’s mission to be the most trusted resource for pet parents and veterinarians.

“Building off our relationship with both pet parents and veterinarians, Chewy is uniquely positioned to make pet healthcare more accessible and affordable for every American household,” said Mita Malhotra, Vice President of Healthcare at Chewy. “By making these types of medications more widely available, we want to better serve pet parents who need a customized solution in an otherwise limited marketplace.”

In addition to the existing broad selection of pharmacy products, this compounded offering from Chewy provides pet owners the ability to order customized, pharmaceutical grade, prescription medications that meet their pets’ unique needs, that cannot be fulfilled by commercially available alternatives.

Chewy Pharmacy’s compounding ingredients are sourced from FDA-registered manufacturers and distributors, and all customized medications are prepared by licensed compounding pharmacists, to the specifications requested by the veterinarian. Customers can order from Chewy in the same way they do their other medications and will receive the same great service, speed and convenience. In the future, the company plans to expand its offering to veterinarians who can utilize the service to provide compounded medication options to their in-clinic customers.

About Chewy

Our mission is to be the most trusted and convenient online destination for pet parents (and partners) everywhere. We believe that we are the preeminent online source for pet products, supplies and prescriptions as a result of our broad selection of high-quality products, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch. We continually develop innovative ways for our customers to engage with us, and partner with more than 2,000 of the best and most trusted brands in the pet industry, to bring a high-bar, customer-centric experience to our customers.

EN
12/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chewy Inc. Class A

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Recurring Revenue, Market Share Gaining Retailer; Outperform, $36 PT

Figure 1. 4Q25 Results vs. EstimatesSource: Company reports, Wedbush estimates, Visible Alpha consensus4Q25 results were healthy. In the quarter, the company reported total revenue of $3.27B (+0.5% Y/Y), above the upper end of management's guide ($3.26B) and in line with St. estimates. Notably, act

Wedbush Research
  • Wedbush Research
W WAYFAIR INC.
XNCR XENCOR INC.
WDC WESTERN DIGITAL CORPORATION
TRIP TRIPADVISOR INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NVCR NOVOCURE LTD.
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
MELI MERCADOLIBRE INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
EXPE EXPEDIA GROUP INC.
ETSY ETSY INC.
EBAY EBAY INC.
AXTI AXT INC.
NFLX NETFLIX INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
CCRN CROSS COUNTRY HEALTHCARE INC.
PTGX PROTAGONIST THERAPEUTICS
CVNA CARVANA CO. CLASS A
ISR ISORAY
SE SEA ADS
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
BKNG BOOKING HOLDINGS INC.
RCUS ARCUS BIOSCIENCES
ARVN ARVINAS HOLDING
STRO SUTRO BIOPHARMA
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
GOSS GOSSAMER BIO
CHWY CHEWY INC. CLASS A
SMCI SUPER MICRO COMPUTER
IDYA INC.
RVMD IDEAYA BIOSCIENCES
ORIC REVOLUTION MEDICINES
ZNTL ORIC PHARMACEUTICALS
COGT ZENTALIS PHARMACEUTICALS
DASH COGENT BIOSCIENCES INC
ABNB DOORDASH
NUVB AIRBNB INC. CLASS A
RBLX NUVATION BIO INC (A)
CGEM ROBLOX
FHTX CULLINAN ONCOLOGY INC
STX FOGHORN THERAPEUTICS
GLUE SEAGATE TECHNOLOGY HLDGS PLC
GFS MONTE ROSA THERAPEUTICS INC
NUVL GLOBALFOUNDRIES INC
CART NUVALENT INC
TLX MAPLEBEAR INC.
BBOT TELIX PHARMACEUTICALS LIMITED
EIKN BRIDGEBIO ONCOLOGY THERAPEUTICS INC
EIKON THERAPEUTICS INC
Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

Counting Clicks: February '26 Traffic Trends

Report Overview: Our analysis includes total web visits (desktop and mobile) to U.S. and international web domains, mobile app monthly active users (MAUs), daily active users (DAUs), and total time spent (where applicable). Throughout the report, we display Y/Y changes across each of these key metr

Chase Tohanczyn ... (+3)
  • Chase Tohanczyn
  • Matthew Weiss
  • Scott Devitt

STARTING SOON: Insights on Agentic Commerce | March 10 | 10AM ET

Host Bio: Scott Devitt is a seasoned equity research analyst specializing in the broader internet space, with an emphasis in the e-commerce and online travel sectors. His interest in the tech space was sparked during his time spent at DELL as a Financial Analyst, where he supported the factory and

ResearchPool Subscriptions

Get the most out of your insights

Get in touch